$SLXP Company News SP shifts to ‘good news is
Post# of 102379
Posted On: 12/13/2013 12:17:00 PM
$SLXP Company News
S&P shifts to ‘good news is good news’ backdrop 12:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
FDA clears Salix anti-diarrheal for HIV patients 6:59 a.m. Jan. 1, 2013 - MarketWatch.com
Salix Pharmaceuticals profit rises 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
Hot Stocks to watch 6:27 a.m. Aug. 9, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 10:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 9:46 a.m. July 30, 2012 - Val Brickates Kennedy
LNKD trade provides a teachable moment 11:02 p.m. March 21, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 4:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 5:17 p.m. Nov. 9, 2011 - Kate Gibson
S&P 500 nails trendline resistance 10:44 a.m. Oct. 7, 2011 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:46 p.m. Feb. 24, 2011 - Kate Gibson
Salix takes center stage in drug-stock trading 12:53 p.m. Feb. 24, 2011 - Val Brickates Kennedy
Salix plunges on FDA setback 10:14 a.m. Feb. 24, 2011 - Val Brickates Kennedy
European drug stocks need a shot in the arm 2:41 a.m. Jan. 13, 2011 - Simon Kennedy
Weak economic data chip away at the technicals 10:00 a.m. Aug. 19, 2010 - Michael Ashbaugh
Thursday's biggest gaining and declining stocks 3:52 p.m. March 25, 2010 - MarketWatch
Genzyme, Poniard drop; Salix, BioMarin jump 12:48 p.m. March 25, 2010 - Val Brickates Kennedy
Now is a good time to buy stocks 12:01 a.m. March 12, 2010 - Kevin Marder
Progenics: Investors Should Remain Cautious Heading Into The Relistor Panel 9:10 a.m. Dec. 5, 2013 - Seeking Alpha
Valeant, Akorn Power Drugmakers Up IBD Industry Ranks 4:59 p.m. Dec. 3, 2013 - Investors Business Daily
Salix Commences Cash Tender Offer for Outstanding Shares of Santarus at $32.00/Share 6:04 a.m. Dec. 3, 2013 - benzinga.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Investors Expect too Much of Salix 6:00 a.m. Dec. 2, 2013 - TheStreet.com
Jazz, Salix Secure Drugmakers' Hold On Leadership 4:49 p.m. Nov. 21, 2013 - Investors Business Daily
2013's Big Winners Having A Rough Week 3:28 a.m. Nov. 21, 2013 - Seeking Alpha
Salix Receives FDA CDRH Approval for Additional Injection Techniques for Deflux 6:04 a.m. Nov. 18, 2013 - benzinga.com
Santarus: To Hold Or Take Profits Now? 8:40 p.m. Nov. 16, 2013 - Seeking Alpha
New Lifetime High Today: Salix Pharmaceuticals (SLXP) 9:46 a.m. Nov. 15, 2013 - TheStreet.com
Narrower Q3 Loss at Progenics - Analyst Blog 9:50 a.m. Nov. 14, 2013 - Zacks.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Salix Pharmaceuticals - Fresh Highs On The Santaurus Deal 3:03 p.m. Nov. 11, 2013 - Seeking Alpha
Narrower-than-Expected Loss at ArQule - Analyst Blog 11:40 a.m. Nov. 11, 2013 - Zacks.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
What Does Salix Really Want With Santarus, And Should You Buy? 3:27 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals: Santarus Acquisition Fortifies Position In Maturing Gastrointestinal Therapeutics Market 1:42 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Santarus 7:01 a.m. Dec. 10, 2013 - BusinessWire
District Court Ruling, Cash Tender Offers, Celebration Events, Conference Presentations, and Repurchase Programs - Research Report on AstraZeneca, Salix, Health Net, Volcano and Portola 8:00 a.m. Dec. 9, 2013 - PR Newswire
Salix Pharmaceuticals Commences Cash Tender Offer for All Outstanding Shares of Santarus 7:01 a.m. Dec. 3, 2013 - BusinessWire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
Court Orders, Stock Price Movements, FDA Approvals and Strategic Collaborations - Research Report on Johnson & Johnson, Santarus, Salix, St. Jude Medical, and Covance 8:00 a.m. Nov. 21, 2013 - PR Newswire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection With Sale of the Company to Salix Pharmaceuticals, Ltd. -- SNTS 2:59 p.m. Nov. 18, 2013 - GlobeNewswire
Salix Announces Approval of Additional Injection Techniques for Deflux(R) 7:00 a.m. Nov. 18, 2013 - BusinessWire
Before the Bell Scans: Zoetis Inc., Avanir Pharma, Actavis PLC, and Salix Pharmaceuticals Ltd 8:01 a.m. Nov. 13, 2013 - PR Newswire
Financial Results, New Appointments, and Stock Price Movements - Research Report on Salix Pharmaceuticals, Cigna, St. Jude Medical, Zimmer, and CareFusion 8:00 a.m. Nov. 13, 2013 - PR Newswire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 12:31 p.m. Nov. 11, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. 11:31 a.m. Nov. 11, 2013 - PR Newswire
Critical Alerts For Salix Pharmaceuticals, Endo Pharmaceuticals, Nektar Therapeutics, Riverbed Technology, and Ubiquiti Networks Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Nov. 8, 2013 - PR Newswire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Nov. 8, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Nov. 8, 2013 - PR Newswire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Nov. 8, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Nov. 8, 2013 - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Nov. 8, 2013 - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Nov. 8, 2013 - PR Newswire
S&P shifts to ‘good news is good news’ backdrop 12:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
FDA clears Salix anti-diarrheal for HIV patients 6:59 a.m. Jan. 1, 2013 - MarketWatch.com
Salix Pharmaceuticals profit rises 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
Hot Stocks to watch 6:27 a.m. Aug. 9, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 10:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 9:46 a.m. July 30, 2012 - Val Brickates Kennedy
LNKD trade provides a teachable moment 11:02 p.m. March 21, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 4:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 5:17 p.m. Nov. 9, 2011 - Kate Gibson
S&P 500 nails trendline resistance 10:44 a.m. Oct. 7, 2011 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:46 p.m. Feb. 24, 2011 - Kate Gibson
Salix takes center stage in drug-stock trading 12:53 p.m. Feb. 24, 2011 - Val Brickates Kennedy
Salix plunges on FDA setback 10:14 a.m. Feb. 24, 2011 - Val Brickates Kennedy
European drug stocks need a shot in the arm 2:41 a.m. Jan. 13, 2011 - Simon Kennedy
Weak economic data chip away at the technicals 10:00 a.m. Aug. 19, 2010 - Michael Ashbaugh
Thursday's biggest gaining and declining stocks 3:52 p.m. March 25, 2010 - MarketWatch
Genzyme, Poniard drop; Salix, BioMarin jump 12:48 p.m. March 25, 2010 - Val Brickates Kennedy
Now is a good time to buy stocks 12:01 a.m. March 12, 2010 - Kevin Marder
Progenics: Investors Should Remain Cautious Heading Into The Relistor Panel 9:10 a.m. Dec. 5, 2013 - Seeking Alpha
Valeant, Akorn Power Drugmakers Up IBD Industry Ranks 4:59 p.m. Dec. 3, 2013 - Investors Business Daily
Salix Commences Cash Tender Offer for Outstanding Shares of Santarus at $32.00/Share 6:04 a.m. Dec. 3, 2013 - benzinga.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Investors Expect too Much of Salix 6:00 a.m. Dec. 2, 2013 - TheStreet.com
Jazz, Salix Secure Drugmakers' Hold On Leadership 4:49 p.m. Nov. 21, 2013 - Investors Business Daily
2013's Big Winners Having A Rough Week 3:28 a.m. Nov. 21, 2013 - Seeking Alpha
Salix Receives FDA CDRH Approval for Additional Injection Techniques for Deflux 6:04 a.m. Nov. 18, 2013 - benzinga.com
Santarus: To Hold Or Take Profits Now? 8:40 p.m. Nov. 16, 2013 - Seeking Alpha
New Lifetime High Today: Salix Pharmaceuticals (SLXP) 9:46 a.m. Nov. 15, 2013 - TheStreet.com
Narrower Q3 Loss at Progenics - Analyst Blog 9:50 a.m. Nov. 14, 2013 - Zacks.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Salix Pharmaceuticals - Fresh Highs On The Santaurus Deal 3:03 p.m. Nov. 11, 2013 - Seeking Alpha
Narrower-than-Expected Loss at ArQule - Analyst Blog 11:40 a.m. Nov. 11, 2013 - Zacks.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
What Does Salix Really Want With Santarus, And Should You Buy? 3:27 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals: Santarus Acquisition Fortifies Position In Maturing Gastrointestinal Therapeutics Market 1:42 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Santarus 7:01 a.m. Dec. 10, 2013 - BusinessWire
District Court Ruling, Cash Tender Offers, Celebration Events, Conference Presentations, and Repurchase Programs - Research Report on AstraZeneca, Salix, Health Net, Volcano and Portola 8:00 a.m. Dec. 9, 2013 - PR Newswire
Salix Pharmaceuticals Commences Cash Tender Offer for All Outstanding Shares of Santarus 7:01 a.m. Dec. 3, 2013 - BusinessWire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
Court Orders, Stock Price Movements, FDA Approvals and Strategic Collaborations - Research Report on Johnson & Johnson, Santarus, Salix, St. Jude Medical, and Covance 8:00 a.m. Nov. 21, 2013 - PR Newswire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection With Sale of the Company to Salix Pharmaceuticals, Ltd. -- SNTS 2:59 p.m. Nov. 18, 2013 - GlobeNewswire
Salix Announces Approval of Additional Injection Techniques for Deflux(R) 7:00 a.m. Nov. 18, 2013 - BusinessWire
Before the Bell Scans: Zoetis Inc., Avanir Pharma, Actavis PLC, and Salix Pharmaceuticals Ltd 8:01 a.m. Nov. 13, 2013 - PR Newswire
Financial Results, New Appointments, and Stock Price Movements - Research Report on Salix Pharmaceuticals, Cigna, St. Jude Medical, Zimmer, and CareFusion 8:00 a.m. Nov. 13, 2013 - PR Newswire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 12:31 p.m. Nov. 11, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. 11:31 a.m. Nov. 11, 2013 - PR Newswire
Critical Alerts For Salix Pharmaceuticals, Endo Pharmaceuticals, Nektar Therapeutics, Riverbed Technology, and Ubiquiti Networks Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Nov. 8, 2013 - PR Newswire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Nov. 8, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Nov. 8, 2013 - PR Newswire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Nov. 8, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Nov. 8, 2013 - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Nov. 8, 2013 - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Nov. 8, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼